# Via Scientific

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/via-scientific

- Industry: Healthcare IT
- Headquarters: Cambridge, US
- Website: www.viascientific.com/
- Total disclosed funding: $4.5M
- Latest round: Seed (Oct 15, 2023)
- Investors on record: 2

## About

Founded in 2022 by James J. Crowley, and Janet Kosloff, and based in Massachusetts, US, Via Scientific, Inc. operates as an Integrated Bioinformatics Operating System that enables scientists and bioinformaticians to generate novel science. In January 2024, Via Scientific, Inc. raised USD 5 million in seed funding co-led by investors G20 Ventures and Innospark Ventures, with participation from another new investor Life Science, and individual investors.

Foundry offers products like vCloud, xCloud, xPrem, and vPro, catering to diverse computing environments, including public clouds and private clusters. The firm’s platform is designed to simplify enterprise-scale multi-omics and analytics, enabling scientists, computational biologists, and bioinformaticians to concentrate on their research rather than managing code and compute infrastructure.

The company intends to use the January 2024 funding to expand its technological and scientific teams, speed up its go-to-market initiatives even more, and add to the hundreds of bioinformatic processes, pipelines, and AI models already in its collection.

## Funding rounds

- Seed, Oct 15, 2023, $4.5M — G20 Ventures, Innospark Ventures

## Investors

- G20 Ventures (https://capitalatlas.ai/funds/g20-ventures) — Seed
- Innospark Ventures (https://capitalatlas.ai/funds/innospark-ventures) — Seed